At the next visit, his wife asked me about the potential causes of chronic inflammation that she’d read about online—tick ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...

The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...

Your body's defense system can mistakenly attack healthy joints, causing inflammatory arthritis. Early signs like persistent ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Novo Nordisk's experimental drug, CagriSema, shows promise beyond weight loss, potentially offering significant ...

A study presented at ACR Convergence 2025 has sparked interest among doctors and patients alike. Drugs originally made for ...